Dahlia Biosciences, Inc. — Form D/A
Dahlia Biosciences, Inc. of ORINDA, CA, a company, filed a Form D amendment with the SEC on 2018-10-05. The offering totals $400K, of which $315K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-10-05
- Form: D/A
- Accession: 0001750916-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $400K
- Amount sold: $315K
- Remaining: $85K
- Investors: 10
- Date of first sale: 2018-08-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-319798
Issuer
- Name: Dahlia Biosciences, Inc.
- CIK: 0001750916
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 21 TARABROOK DRIVE, ORINDA, CA, 94563
- Phone: 415-359-8013
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Un Casado | Director | Orinda, CA |
| Un Casado | Executive Officer | Orinda, CA |
Other filings by this issuer (1)
More